000 | 01862 a2200553 4500 | ||
---|---|---|---|
005 | 20250513165125.0 | ||
264 | 0 | _c19990303 | |
008 | 199903s 0 0 eng d | ||
022 | _a0950-9232 | ||
024 | 7 |
_a10.1038/sj.onc.1202421 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSala, A | |
245 | 0 | 0 |
_aB-MYB transactivates its own promoter through SP1-binding sites. _h[electronic resource] |
260 |
_bOncogene _cFeb 1999 |
||
300 |
_a1333-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenovirus E1A Proteins _xmetabolism |
650 | 0 | 4 | _aBinding Sites |
650 | 0 | 4 | _aCell Cycle Proteins |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aDNA-Binding Proteins _xgenetics |
650 | 0 | 4 |
_aFungal Proteins _xgenetics |
650 | 0 | 4 |
_aHerpes Simplex Virus Protein Vmw65 _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
650 | 0 | 4 |
_aOligonucleotides _xpharmacology |
650 | 0 | 4 | _aPromoter Regions, Genetic |
650 | 0 | 4 | _aProtein Binding |
650 | 0 | 4 |
_aProto-Oncogene Proteins _xmetabolism |
650 | 0 | 4 | _aProto-Oncogene Proteins c-myb |
650 | 0 | 4 | _aRecombinant Fusion Proteins |
650 | 0 | 4 | _aSaccharomyces cerevisiae Proteins |
650 | 0 | 4 |
_aSp1 Transcription Factor _xgenetics |
650 | 0 | 4 | _aSp3 Transcription Factor |
650 | 0 | 4 |
_aTrans-Activators _xgenetics |
650 | 0 | 4 |
_aTranscription Factors _xgenetics |
650 | 0 | 4 | _aTranscription, Genetic |
650 | 0 | 4 |
_aTranscriptional Activation _xdrug effects |
650 | 0 | 4 | _aTransfection |
700 | 1 | _aSaitta, B | |
700 | 1 | _aDe Luca, P | |
700 | 1 | _aCervellera, M N | |
700 | 1 | _aCasella, I | |
700 | 1 | _aLewis, R E | |
700 | 1 | _aWatson, R | |
700 | 1 | _aPeschle, C | |
773 | 0 |
_tOncogene _gvol. 18 _gno. 6 _gp. 1333-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.onc.1202421 _zAvailable from publisher's website |
999 |
_c9984178 _d9984178 |